Robustness of intratumour 18 F-FDG PET uptake heterogeneity quantification for therapy response prediction in ooesophageal carcinoma

Mathieu Hatt, Florent Tixier, Catherine Cheze Le Rest, Olivier Pradier, Dimitris Visvikis. Robustness of intratumour F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.: Robustness of FDG PET tumour heterogeneity quantification. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2013, 40 (11), pp.1662-71. <10.1007/s00259-013-2486-8>. <inserm-00845976>

[1]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[2]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[3]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[4]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Christian Roux,et al.  A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET , 2009, IEEE Transactions on Medical Imaging.

[6]  M. Hatt,et al.  Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.

[7]  Shan Tan,et al.  Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[8]  Kyung Soo Lee,et al.  Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications , 2010, Annals of Surgical Oncology.

[9]  Florent Tixier,et al.  The age of reason for FDG PET image-derived indices , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Dimitris Visvikis,et al.  Reproducibility of 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Tumor Volume Measurements , 2010, The Journal of Nuclear Medicine.

[11]  B J Krause,et al.  (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[12]  Farrokh Dehdashti,et al.  Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[14]  Vicky Goh,et al.  Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? , 2013, The Journal of Nuclear Medicine.

[15]  M. Souvatzoglou,et al.  FDG PET and PET/CT. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[16]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[17]  Ronald Boellaard,et al.  Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  S. Rottey,et al.  Metabolic tumour volume , 2011, Nuklearmedizin.

[19]  Vicky Goh,et al.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  B. C. Penney,et al.  Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[22]  Finbarr O'Sullivan,et al.  A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma , 2011, IEEE Transactions on Medical Imaging.

[23]  Maximilien Vermandel,et al.  Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  D. Visvikis,et al.  Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[26]  Drew A. Torigian,et al.  Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  R. Jeraj,et al.  Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters , 2010, Acta oncologica.

[28]  Dimitris Visvikis,et al.  PET functional volume delineation: a robustness and repeatability study , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  M. Choti,et al.  Efficacy of Preoperative Combined 18-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for Assessing Primary Rectal Cancer Response to Neoadjuvant Therapy , 2007, Journal of Gastrointestinal Surgery.

[30]  M. Hatt,et al.  Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer , 2013, The Journal of Nuclear Medicine.

[31]  Dimitris Visvikis,et al.  Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. , 2010, International journal of radiation oncology, biology, physics.

[32]  D. Visvikis,et al.  The role of PET/CT scanning in radiotherapy planning. , 2006, The British journal of radiology.